3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Neuroendocrine Tumors
5
Neoplasm Metastasis
3
Carcinoma, Renal Cell
3
Tuberous Sclerosis
2
Triple Negative Breast Neoplasms
2
Recurrence
2
Glioma
2
Endometrial Neoplasms
2
Adenoma, Islet Cell
2
von Hippel-Lindau Disease
1
Vascular Malformations
1
Unilateral Breast Neoplasms
1
Thymus Neoplasms
1
Seizures
1
Sarcoma, Kaposi
1
Sarcoma
1
Nevus
1
Myelodysplastic Syndromes
1
Multiple Endocrine Neoplasia Type 1
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Lymphangioma
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Kidney Neoplasms
1
Hemangioma
1
Hemangioendothelioma
1
Hamartoma Syndrome, Multiple
1
Interventions
Cyclophosphamide
48
fludarabine
32
Methotrexate
24
blinatumomab
20
fludarabine phosphate
19
Dexamethasone
19
Vincristine
18
Whole-Body Irradiation
16
Specimen Handling
16
Cytarabine
16
Tacrolimus
14
Mycophenolic Acid
14
Peripheral Blood Stem Cell Transplantation
13
Melphalan
13
Mercaptopurine
12
Calcium Dobesilate
12
merphos
11
Busulfan
11
Biopsy
11
Magnetic Resonance Spectroscopy
10
Etoposide
10
Stem Cell Transplantation
9
Prednisone
9
Granulocyte Colony-Stimulating Factor
9
Cyclosporine
9
Thiotepa
8
Rituximab
8
Mesna
8
Filgrastim
8
Doxorubicin
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Everolimus
×
90 days
×
Clear all
No trials found.